SBI Securities’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History

SBI Securities’s Portfolio CYTH Stock Details CYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11	Closed	-$6	–	4228
2024 Q4	$6	Buy	+11	New	+$8	﹤0.01%	3989

SBI Securities's CYTH Position: Q1 2025 in Review

SBI Securities sold out of Cyclo Therapeutics, Inc. Common Stock (CYTH) in Q1 2025, closing a stake of 11 shares — an estimated $6 sold.

SBI Securities first reported a position in CYTH in Q4 2024 and held it in 1 quarter. The position peaked at $6 in Q4 2024. 0 funds tracked by Wall St. Rank hold CYTH as of Q1 2025.

SBI Securities reported no remaining Cyclo Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
SBI Securities sold 11 Cyclo Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $6.
SBI Securities first reported a position in Cyclo Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
SBI Securities's Cyclo Therapeutics, Inc. Common Stock position peaked at $6 in Q4 2024.
0 funds tracked by Wall St. Rank held Cyclo Therapeutics, Inc. Common Stock as of Q1 2025.

Based on SBI Securities's 13F filing for Q1 2025, filed 2 May 2025.